Article Text

Download PDFPDF

Correction: Toll-like reReceptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16 subset

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Veneziani I, Alicata C, Pelosi A, et al. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16 subset. J Immunother Cancer 2022;10:e003385. doi:10.1136/jitc-2021-003385

This article has been corrected since it was first published. An error with figure 2 and the supplemental material has been amended.